Federal Register: FDA Reclassifies DermaSensor Inc. AI-Powered Skin Cancer Diagnostic Device to Expand Clinical Access
October 31, 2026
October 31, 2026
WASHINGTON, Oct. 31 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register.
* * *
Medical Devices; General and Plastic Surgery Devices; Classification of the Software-Aided Adjunctive Diagnostic Device for Use by Physicians on Lesions Suspicious for Skin Cancer
The Food and Drug Administration (FDA) is classifying the software-aided adjunctive diagnostic device for use by . . .
* * *
Medical Devices; General and Plastic Surgery Devices; Classification of the Software-Aided Adjunctive Diagnostic Device for Use by Physicians on Lesions Suspicious for Skin Cancer
The Food and Drug Administration (FDA) is classifying the software-aided adjunctive diagnostic device for use by . . .